Category: Pharmaceuticals
United States Pharmaceuticals
-
Herpes Marker Testing
... by 2030, growing at a CAGR of 4.9% over the analysis period 2023-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$279.9 Million ... Read More
-
Swine Health
... at a CAGR of 5.8% over the analysis period 2023-2030. Antibiotics, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$2.5 Billion by the end of the ... Read More
-
Vial Adaptors for Reconstitution Drug
... Billion by 2030, growing at a CAGR of 6.2% over the analysis period 2023-2030. Polycarbonate Material, one of the segments analyzed in the report, is expected to record a 6.8% CAGR and reach US$1.3 Billion ... Read More
-
United States Next Generation Sequencing Market Report by Products (Instruments, Reagents & Consumables, and Services), Application (Diagnostics, Agriculture and Animal Research, Drug Discovery, Personalized Medicine and Genetic Screening, and Others), Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032
... Semiconductor Sequencing, Single-Molecule Read Time Sequencing, Nanopore Sequencing, and Others), End-Users(Academic and Clinical Research Centers, Pharmaceutical and Biotechnology Companies, Hospitals and Clinics, and Others), and Company Analysis 2024-2032 United States Next Generation Sequencing Market Size ... Read More
-
Local Anesthesia Drugs
... at a CAGR of 5.0% over the analysis period 2023-2030. Lidocaine, one of the segments analyzed in the report, is expected to record a 4.6% CAGR and reach US$1.6 Billion by the end of the ... Read More
-
Gensets
... of 5.6% over the analysis period 2023-2030. Diesel Gensets, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$25.1 Billion by the end of the analysis period. ... Read More
-
Hepatitis B Vaccines
... by 2030, growing at a CAGR of 4.3% over the analysis period 2023-2030. Adult Application, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$2.7 Billion by ... Read More
-
Home Care Services
... by 2030, growing at a CAGR of 7.3% over the analysis period 2023-2030. Maid Services, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$22.7 Billion by ... Read More
-
Hydroponics
... of 14.2% over the analysis period 2023-2030. Aggregate Systems, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$8.1 Billion by the end of the analysis period. ... Read More
-
Family Planning Centers
... by 2030, growing at a CAGR of 3.3% over the analysis period 2023-2030. Birth Control Clinics, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$4.5 Billion ... Read More
-
Spring and Wire Products
... reach US$82.0 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Springs, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$47.0 ... Read More
-
Intracranial Aneurysm
... CAGR of 8.5% over the analysis period 2023-2030. Endovascular Coiling, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.3 Billion by the end of the analysis ... Read More
-
Medical Marijuana Dispensaries in the US - Industry Market Research Report
... Medical marijuana is most used for pain control, typically to ease chronic pain. Marijuana can additionally be used to manage nausea, anxiety, and weight loss. The legalization of marijuana for medical purposes and the growing ... Read More
-
Vision Insurance in the US - Industry Market Research Report
... Profitability was bolstered from cost efficiencies associated with high levels of enrollment for individual providers. However, slight fluctuations in the percent of the population enrolled in vision plans, coupled with a spike in unemployment during ... Read More
-
Healthcare Consultants in the US - Industry Market Research Report
... manage risk. Over the five years to 2023, demand for healthcare consultants has increased because of technological advances in healthcare-related industries and the changing regulatory environment. Moreover, the 2010 Patient Protection and Affordable Care Act ... Read More
-
Transmucosal Drug Delivery Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update
... Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update provides comprehensive information about the Transmucosal Drug Delivery pipeline products with comparative analysis of the products at various stages of development and information about ... Read More
-
Medical & Recreational Marijuana Growing in the US - Industry Market Research Report
... over the five years to 2023. Legislative victories over recent years, proved that the cannabis industry is one of the fastest growing industries in the US. Consumer attitudes are also accelerating legalization efforts at the ... Read More
-
U.S. Vitamin Gummies Market - Focused Insights 2024-2029
... gummies are chewable supplements enhanced with additional vitamins, minerals, or other nutrients. These fortified gummies are getting traction in the U.S. vitamin gummies market. These chewable vitamins have become a popular alternative to traditional pills ... Read More
-
Vitamin & Supplement Manufacturing in the US - Industry Market Research Report
... research on diet-related illnesses have encouraged consumers of all ages to turn to dietary supplements. Due to increased demand for health supplements caused by the COVID-19 outbreak, industry revenue grew at a CAGR of 1.6% ... Read More
-
NRT Smoking Cessation Aids in the US
... NRT gum is the only one projected to report positive current value growth, with NRT lozenges and patches set to decline. Notably, NRT patches is expected to see solid declines in current value terms over ... Read More
-
Cough, Cold and Allergy (Hay Fever) Remedies in the US
... normalisation after the extreme double-digit growth brought about by the “tripledemic” in 2022. While most paediatric and adult cough and cold categories are expected to see slight negative growth in 2024, overall decline is mainly ... Read More
-
Vitamins in the US
... more holistic approach to healthcare, focusing on prevention rather than treatment. Inflation is hampering demand, as retail prices are on the rise, and consumers are feeling the squeeze on their purchasing power. Nevertheless, Euromonitor International’s ... Read More
-
Herbal/Traditional Products in the US
... are increasingly seeking out natural products to reduce their exposure to the chemical ingredients in standard products. This trend is also being driven by the increasing number of vegans in the US, leading to higher ... Read More
-
Dermatologicals in the US
... prices, which excludes the impact of inflation, 2024 is expected to post a marginal value decline, which is actually a slight improvement on the decline witnessed in 2023. While pandemic-driven behaviours such as social distancing ... Read More
-
Dietary Supplements in the US
... growth then stabilised, and in 2024 dietary supplements is set to see steady mid-single-digit retail current value growth in the US. However, there are mixed results, with volumes set to soften, while value growth is ... Read More
Research Assistance
